🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › Georgia › Atlanta

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Atlanta, GA

Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Atlanta VA Medical Center, Decatur · 6 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Nagre-recruitPhase 3
  • Emory University Winship Cancer Institute, Atlanta
  • Northside Cancer Center, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06846671

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 1
  • Winship Cancer Institute Emory University, Atlanta
  • Northside Hospital Cancer Institute, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Northside Hospital, Atlanta
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07020533

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

Nagre-recruitObservasyonal na pag-aaral
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT03501576

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1
  • Winship Cancer Institute of Emory University, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
  • Northside Hospital, Atlanta
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT06059391

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Nagre-recruitPhase 4
  • The Emory Clinic, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Nagre-recruitPhase 4
  • The Emory Clinic, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Nagre-recruitPhase 2
  • Winship Cancer Institute of Emory University /ID# 230643, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT04895436

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

Nagre-recruitPhase 2
  • Winship Cancer Institute at Emory University, Atlanta
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06043674

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Atlanta

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.